Literature DB >> 26446417

miR-205 promotes epithelial-mesenchymal transition by targeting AKT signaling in endometrial cancer cells.

Chenyu Jin1, Ruojia Liang2.   

Abstract

AIM: AKT signaling regulates multiple biological processes and expresses in various cancers. miR-205 plays complex roles in tumorigenesis and tumor progression by acting either as a tumor suppressor or an oncogene depending on the tumor type. Here we describe the molecular mechanism of miR-205 regulating epithelial-mesenchymal transition by activation of AKT signaling in endometrial cancer cells HEC-50B and HEC-1-A.
MATERIAL AND METHODS: The proliferation of HEC-50B cells transfected with miR-205 mimic was assessed by WST-1 assay. The migration and invasion were evaluated by BD transwell migration and matrigel invasion assays. The EMT markers were detected by Western blot.
RESULTS: We found that miR-205 increased the proliferation in HEC-50B cells. The migration and invasion of HEC-50B cells and HEC-1-A cells were enhanced by miR-205. When HEC-50B cells and HEC-1-A cells were treated with anti-miR-205 inhibitor, the migration and invasion were decreased as compared with the negative control. The overexpression of miR-205 inhibited E-cadherin expression and promoted Snail expression by activation of AKT and downregulation of glycogen synthase kinase 3β. However, after the HEC-50B cells and HEC-1-A cells were treated with anti-miR-205 inhibitor, E-cadherin expression was increased and Snail protein level was decreased by inhibition of AKT expression.
CONCLUSION: Our data strongly suggest that miR-205 plays an important role in endometrial cancer migration and invasion by targeting the AKT pathway. Our data highlight miR-205 as a potential molecular target for endometrial cancer treatment.
© 2015 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  AKT; endometrial cancer; epithelial-mesenchymal transition; glycogen synthase kinase 3β; miR-205

Mesh:

Substances:

Year:  2015        PMID: 26446417     DOI: 10.1111/jog.12756

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  15 in total

1.  The important application of thioridazine in the endometrial cancer.

Authors:  Qiong Meng; Xiao Sun; Jing Wang; Yudong Wang; Lihua Wang
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

Review 2.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

Review 3.  Non-Coding RNAs in Endometrial Physiopathology.

Authors:  Alessandro La Ferlita; Rosalia Battaglia; Francesca Andronico; Salvatore Caruso; Antonio Cianci; Michele Purrello; Cinzia Di Pietro
Journal:  Int J Mol Sci       Date:  2018-07-20       Impact factor: 5.923

4.  MicroRNA-205 is downregulated in hepatocellular carcinoma and inhibits cell growth and metastasis via directly targeting vascular endothelial growth factor A.

Authors:  Xuya Zhao; Shi Zhou; Dazhi Wang; Wei He; Junxiang Li; Shuai Zhang
Journal:  Oncol Lett       Date:  2018-06-08       Impact factor: 2.967

5.  The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma.

Authors:  Max Michael Traeger; Jan Rehkaemper; Hansjoerg Ullerich; Konrad Steinestel; Eva Wardelmann; Norbert Senninger; Sameer Abdallah Dhayat
Journal:  J Cancer Res Clin Oncol       Date:  2018-09-22       Impact factor: 4.553

6.  High tumor-associated macrophages infiltration is associated with poor prognosis and may contribute to the phenomenon of epithelial-mesenchymal transition in gastric cancer.

Authors:  Yan Yan; Jia Zhang; Jun-Hai Li; Xu Liu; Ji-Zhao Wang; Hang-Ying Qu; Jian-Sheng Wang; Xiao-Yi Duan
Journal:  Onco Targets Ther       Date:  2016-06-30       Impact factor: 4.147

7.  HMGB1 is negatively correlated with the development of endometrial carcinoma and prevents cancer cell invasion and metastasis by inhibiting the process of epithelial-to-mesenchymal transition.

Authors:  Xiaorong Luan; Chunjing Ma; Ping Wang; Fenglan Lou
Journal:  Onco Targets Ther       Date:  2017-03-03       Impact factor: 4.147

8.  Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.

Authors:  Tiantian Wang; Mei Wang; Shuang Fang; Qiang Wang; Rui Fang; Jie Chen
Journal:  Oncotarget       Date:  2017-03-21

9.  MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial-mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells.

Authors:  Yibing Li; Jianing Huo; Xin Pan; Cuicui Wang; Xiaoxin Ma
Journal:  Onco Targets Ther       Date:  2018-03-06       Impact factor: 4.147

10.  LncRNA TTN‑AS1 promotes endometrial cancer by sponging miR‑376a‑3p.

Authors:  Longde Shen; Yinyin Wu; Ailu Li; Lichun Li; Longyuan Shen; Qiuxia Jiang; Qiuxia Li; Zhifen Wu; Liji Yu; Xiaohong Zhang
Journal:  Oncol Rep       Date:  2020-07-15       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.